Cardiac remodeling and dysfunction in nephrotic syndrome

Kidney International

Volumn 71, Issue 12, 2007, Pages 1240-1248

  Moreira Rodrigues, M ^a   Roncon Albuquerque Jr , R ^b   Henriques Coelho, T ^b   Lourenco A P ^b   Sampaio Maia, B ^a   Santos, J ^a   Pestana, M ^a   Leite Moreira, A F ^b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c Institute of Histology and Embryology   (Portugal)

Author keywords

Cardiovascular; Cytokines; Nephrotic syndrome; Proteinuria; Renal function

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CREATININE; CYTOKINE; INTERLEUKIN 1BETA; PHOSPHOLAMBAN; PROTEIN; PUROMYCIN AMINONUCLEOSIDE; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM METABOLISM; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE PRODUCTION; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HEART; HEART DISEASE; HEART FUNCTION TEST; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE REMODELING; HEMODYNAMICS; INFLAMMATION; KIDNEY FUNCTION; MALE; MORPHOMETRICS; MUSCLE ATROPHY; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEINURIA; RAT; REAL TIME POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; SODIUM BALANCE;

ANIMALS; BLOOD PRESSURE; CALCIUM-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION; HEART VENTRICLES; INTERLEUKIN-1BETA; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOCARDIUM; NEPHROTIC SYNDROME; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; WATER-ELECTROLYTE BALANCE;

EID: 34250030219     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002204     Document Type: Article

References (54)

1. Cupisti A, Chisari C, Morelli E et al. Abnormal increase of creatine kinase plasma levels following muscle exercise in nephrotic patients. Nephron 1998; 80: 204-207.
2. de Sain-Van Der Velden MG, de Meer K, Kulik W et al. Nephrotic proteinuria has no net effect on total body protein synthesis: measurements with (13)C valine. Am J Kidney Dis 2000; 35: 1149-1154.
3. Kaysen GA, Carstensen A, Martin VI. Muscle protein synthesis is impaired in nephrotic rats. Miner Electrolyte Metab 1992; 18: 228-232.
4. Maroni BJ, Staffeld C, Young VR et al. Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. J Clin Invest 1997; 99: 2479-2487.
5. Thabet MA, Challa A, Chan W et al. Insulin-like growth factor and growth hormone receptor in nephrotic rats. Am J Physiol 1994; 266: E102-E106.
6. Bustos C, Gonzalez E, Muley R et al. Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994; 24: 799-805.
7. Suranyi MG, Guasch A, Hall BM et al. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 1993; 21: 251-259.
8. Gomez-Chiarri M, Ortiz A, Lerma JL et al. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 1994; 70: 449-459.
9. Martin A, Molina A, Bricio T et al. Passive dual immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta maximally ameliorates acute aminonucleoside nephrosis. Clin Exp Immunol 1995; 99: 283-288.
10. Raveh D, Shemesh O, Ashkenazi YJ et al. Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome. Pediatr Nephrol 2004; 19: 1281-1284.
11. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287: C834-C843.
12. Moldawer LL, Copeland III EM. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer 1997; 79: 1828-1839.
13. Testa M, Yeh M, Lee P et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996; 28: 964-971.
14. Torre-Amione G, Kapadia S, Lee J et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-711.
15. Torre-Amione G, Kapadia S, Lee J et al. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995; 92: 1487-1493.
16. Yokoyama T, Vaca L, Rossen RD et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92: 2303-2312.
17. Li YY, Kadokami T, Wang P et al. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure. Am J Physiol Heart Circ Physiol 2002; 282: H983-H989.
18. Sivasubramanian N, Coker ML, Kurrelmeyer KM et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001; 104: 826-831.
19. Ordonez JD, Hiatt RA, Killebrew EJ et al. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 1993; 44: 638-642.
20. Watts GF, Herrmann S, Dogra GK et al. Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int 2001; 60: 182-189.
21. Dogra GK, Herrmann S, Irish AB et al. Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant 2002; 17: 2220-2225.
22. Adedoyin O, Frank R, Vento S et al. Cardiac disease in children with primary glomerular disorders-role of focal segmental glomerulosclerosis. Pediatr Nephrol 2004; 19: 408-412.
23. Deschenes G, Doucet A. Collecting duct (Na+/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol 2000; 11: 604-615.
24. Humphreys MH. Mechanisms and management of nephrotic edema. Kidney Int 1994; 45: 266-281.
25. van der Vijgh WJ, Van Velzen D, Van der Poort JS et al. Morphometric study of myocardial changes during puromycin aminonucleoside induced nephropathy in rats. Anticancer Res 1987; 7: 1111-1115.
26. Correia Pinto J, Henriques-Coelho T, Roncon-Albuquerque Jr R et al. Differential right and left ventricular diastolic tolerance to acute afterload and NCX gene expression in Wistar rats. Physiol Res 2006; 55: 513-526.
27. Endoh M. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. Eur J Pharmacol 2004; 500: 73-86.
28. Welsh DC, Dipla K, McNulty PH et al. Preserved contractile function despite atrophic remodeling in unloaded rat hearts. Am J Physiol Heart Circ Physiol 2001; 281: H1131-H1136.
29. Egan JR, Butler TL, Au CG et al. Myocardial water handling and the role of aquaporins. Biochim Biophys Acta 2006; 1758: 1043-1052.
30. Nakamura H, Umemoto S, Naik G et al. Induction of left ventricular remodeling and dysfunction in the recipient heart after donor heart myocardial infarction: new insights into the pathologic role of tumor necrosis factor-alpha from a novel heterotopic transplant-coronary ligation rat model. J Am Coll Cardiol 2003; 42: 173-181.
31. Haffner D, Tonshoff B, Blum WF et al. Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children. Kidney Int 1997; 52: 802-810.
32. Lee DY, Park SK, Kim JS. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children with nephrotic syndrome. J Clin Endocrinol Metab 1996; 81: 1856-1860.
33. Zhou X, Loke KY, Pillai CC et al. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH. Eur J Endocrinol 2001; 144: 237-243.
34. Dong F, Ren J. Insulin-like growth factors (IGFs) and IGF-binding proteins in nephrotic syndrome children on glucocorticoid. Pharmacol Res 2003; 48: 319-323.
35. Pedersen EB, Danielsen H, Eiskjaer H et al. Increased atrial natriuretic peptide in the nephrotic syndrome. Relationship to the renal function and the renin-angiotensin-aldosterone system. Scand J Clin Lab Invest 1988; 48: 141-147.
36. Plum J, Mirzaian Y, Grabensee B. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome. Nephrol Dial Transplant 1996; 11: 1034-1042.
37. Pikkarainen S, Tokola H, Kerkela R et al. Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors. J Biol Chem 2003; 278: 3969-3975.
38. van Wamel JE, Ruwhof C, van der Valk-Kokshoorn EJ et al. Rapid gene transcription induced by stretch in cardiac myocytes and fibroblasts and their paracrine influence on stationary myocytes and fibroblasts. Pflugers Arch 2000; 439: 781-788.
39. Perico N, Remuzzi G. Renal handling of sodium in the nephrotic syndrome. Am J Nephrol 1993; 13: 413-421.
40. He Q, LaPointe MC. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 1999; 33: 283-289.
41. Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004; 36: 505-513.
42. Studzinski GP, Ellem KA. Relationship between RNA synthesis, cell division, and morphology of mammalian cells. I. Puromycin aminonucleoside as an inhibitor of RNA synthesis and division in HeLa cells. J Cell Biol 1966; 29: 411-421.
43. Allen DW, Zamecnik PC. The effect of puromycin on rabbit reticulocyte ribosomes. Biochim Biophys Acta 1962; 55: 865-874.
44. Hofert JF, Boutwell RK. Puromycin-induced glycogenolysis as an even independent from inhibited protein synthesis in mouse liver; effects of puromycin analogs. Arch Biochem Biophys 1963; 103: 338-344.
45. Nathans D, Neidle A. Structural requirements for puromycin inhibition of protein synthesis. Nature 1963; 197: 1076-1077.
46. Rabinovitz M, Fisher JM. A dissociative effect of puromycin on the pathway of protein synthesis by Ehrlich ascites tumor cells. J Biol Chem 1962; 237: 477-481.
47. Sidhu JS, Omiecinski CJ. Protein synthesis inhibitors exhibit a nonspecific effect on phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocytes. J Biol Chem 1998; 273: 4769-4775.
48. Chow SC, Peters I, Orrenius S. Reevaluation of the role of de novo protein synthesis in rat thymocyte apoptosis. Exp Cell Res 1995; 216: 149-159.
49. Kawashima A, Chiku K, Kawashima M et al. Effect of varying amino acid levels on protein metabolism in nephrotic rats during total parenteral nutrition. J Am Soc Nephrol 1997; 8: 1399-1404.
50. Derr RF, Alexander CS, Nagasawa HT. Metabolism of puromycin aminonucleoside in the normal, 'pre-nephrotic,' and nephrotic rat. Proc Soc Exp Biol Med 1967; 125: 248-252.
51. Soares-da-Silva P, Fernandes MH, Pestana M. Studies on the role of sodium on the synthesis of dopamine in the rat kidney. J Pharmacol Exp Ther 1993; 264: 406-414.
52. Adler CP. Relationship between deoxyribonucleic acid content and nucleoli in human heart muscle cells and estimation of cell number during cardiac growth and hyperfunction. Recent Adv Stud Cardiac Struct Metab 1975; 8: 373-386.
53. Murotsuki J, Challis JR, Han VK et al. Chronic fetal placental embolization and hypoxemia cause hypertension and myocardial hypertrophy in fetal sheep. Am J Physiol 1997; 272: R201-R207.
54. Gillebert TC, Leite-Moreira AF, De Hert SG. Load dependent diastolic dysfunction in heart failure. Heart Fail Rev 2000; 5: 345-355.